$P-274 Rigosertib activity in patients with a myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) relapsed or refractory to hypomethylating agents$

P-274 Rigosertib activity in patients with a myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) relapsed or refractory to hypomethylating agents

Navada, S.C.; Odchimar-Reissig, R.; Reddy, E.P.; Demakos, E.P.; Holland, J.F.; Wilhelm, F.; Silverman, L.R.

期刊名称Leukemia Research
作者Navada, S.C.; Odchimar-Reissig, R.; Reddy, E.P.; Demakos, E.P.; Holland, J.F.; Wilhelm, F.; Silverman, L.R.
卷第37卷
印刷ISSN0145-2126
文件大小67.78KB
发表时间2013-5
DOI10.1016/S0145-2126(13)70321-7

发现好书期刊，享受阅读乐趣

P-274 Rigosertib activity in patients with a myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) relapsed or refractory to hypomethylating agents